Search results
Search for "tumor targeting" in Full Text gives 28 result(s) in Beilstein Journal of Nanotechnology.
Tailoring the ligand shell for the control of cellular uptake and optical properties of nanocrystals
Beilstein J. Nanotechnol. 2015, 6, 232–242, doi:10.3762/bjnano.6.22
- one hand do not show any unspecific interaction with the cells under default conditions with serum containing medium. On the other hand, the nanocontainers are in a good size range and can in general be internalized by the cells. First experiments in tumor targeting with antibody coupled QDs and iron
Anticancer efficacy of a supramolecular complex of a 2-diethylaminoethyl–dextran–MMA graft copolymer and paclitaxel used as an artificial enzyme
Beilstein J. Nanotechnol. 2014, 5, 2293–2307, doi:10.3762/bjnano.5.238
- increasing concentrations of PTX, for example, Miyano has conducted extensive research into the resistance of these cells to PTX by using systems biology [35]. In addition, for a taxoid-based tumor-targeting drug, the resistance gene Taxol-resistant-associated protein 3 (TRAG-3) was identified in cancer
Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer
Beilstein J. Nanotechnol. 2014, 5, 937–945, doi:10.3762/bjnano.5.107
- toxicity by incorporating mechanisms for targeted delivery of chemotherapeutics. Nanomedicine has become a viable solution for the specificity and toxicity problems with current chemotherapy treatment regimens [6][7][8][9]. Nanoparticles have facilitated tumor targeting and drug delivery in a variety of
- ]. Liang et al. demonstrated that DOX-loaded micelles can efficiently use the tumor-targeting function of RGD sequence to deliver the drug into HeLa cells [38]. Tian et al. showed that iRGD exosomes delivered DOX specifically to tumor tissues and inhibited tumor growth without overt toxicity [39]. Zhou et
Other Beilstein-Institut Open Science Activities
